|
|
楼主 |
发表于 2015-1-31 09:55:59
|
显示全部楼层
目录:6 x" w; L4 S- W$ `. n: F5 n
Virus Infection and Human Cancer: An Overview . . . . . . . . . . . . . . . 1
4 t" i% d; o. t9 C3 h4 mJohn T. Schiller and Douglas R. Lowy
: f0 v8 z+ _1 }" DEpidemiology of Virus Infection and Human Cancer . . . . . . . . . . . . . 11
f" t) C+ q; s+ i$ V- d+ W6 F4 QChien-Jen Chen, Wan-Lun Hsu, Hwai-I Yang, Mei-Hsuan Lee,
' V ^: K( X# R6 WHui-Chi Chen, Yin-Chu Chien and San-Lin You
4 n0 Y# i$ t* S) GVirus Infection, Inflammation and Prevention of Cancer . . . . . . . . . . 331 W/ H+ f, A4 F4 l, p9 j
Norman Woller and Florian Kühnel
2 Q+ T% t j$ WThe Oncogenic Role of Hepatitis B Virus . . . . . . . . . . . . . . . . . . . . . . 59
9 ]; X. J; X7 d: `, ]Lise Rivière, Aurélie Ducroux and Marie Annick Buendia
7 m5 \1 Z3 N7 f4 l1 @$ j4 o6 n/ y+ lPrevention of Hepatitis B Virus Infection and Liver Cancer . . . . . . . . 75
8 @7 q# h1 Y( hMei-Hwei Chang2 S8 T0 J# ~7 U+ d9 A
The Oncogenic Role of Hepatitis C Virus. . . . . . . . . . . . . . . . . . . . . . 97- ?+ U5 a2 B/ D/ y2 v# D
Kazuhiko Koike) g; }" l! p& A+ X. e( F2 S1 k, ^
Prevention of Hepatitis C Virus Infection and Liver Cancer . . . . . . . . 113
( W" N5 J6 H4 s: f3 _7 C3 ?E. J. Lim and J. Torresi
, U- x, d& N* A8 a$ Y" DThe Role of Human Papillomaviruses in Oncogenesis . . . . . . . . . . . . . 135+ ]7 }" e8 H% T& t9 J
Kristen K. Mighty and Laimonis A. Laimins' P% ^* l/ t" M6 U
Control of HPV Infection and Related Cancer, L r' Q* k6 b4 h
Through Vaccination. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1496 X, P9 c' v& e+ O6 A; b
Nam Phuong Tran, Chien-Fu Hung, Richard Roden and T.-C. Wu0 ]0 Z% b5 _9 m0 h* J* F8 j, }/ S; E
Prevention and Treatment for Epstein–Barr Virus Infection
# A2 |# z4 m% {1 Uand Related Cancers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
( H, T; M$ O# FFrançoise Smets and Etienne M. Sokal6 k4 a& A9 ^5 B0 c
HTLV-1 and Leukemogenesis: Virus–Cell Interactions
* C' ]0 I) a; l0 C) X+ _+ i0 }0 Pin the Development of Adult T-Cell Leukemia . . . . . . . . . . . . . . . . . . 191
# s/ ^: A2 k9 ]/ o, J& D) yLinda Zane and Kuan-Teh Jeang
" C/ j0 d X8 f$ ]Prevention of Human T-Cell Lymphotropic Virus Type 1
! }8 x" C6 k7 I! x" q$ |Infection and Adult T-Cell Leukemia/Lymphoma. . . . . . . . . . . . . . . . 211. T: \' z4 S9 d' i: B0 t9 G& i
Makoto Yoshimitsu, Yohann White and Naomichi Arima, d6 X1 P& y2 G. x( L3 S( M
Molecular Biology of Human Herpesvirus 8: Novel Functions3 c$ U) V4 P" }; U
and Virus–Host Interactions Implicated in Viral Pathogenesis0 {) h3 v. T" y' H. i1 Y
and Replication . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227
# R* E) O: _2 f/ pEmily Cousins and John Nicholas: v3 C5 C: k$ {, s
Anti-Viral Treatment and Cancer Control . . . . . . . . . . . . . . . . . . . . . 269" k) Q. q5 K* |: L, S: U4 k
Wei-Liang Shih, Chi-Tai Fang and Pei-Jer Chen |
|